Related Experiment Video
Updated: Oct 14, 2025
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.7K
[HIV resistance to non-nucleoside reverse transcriptase inhibitors]
1Laboratoire de virologie, Hôpital Necker-Enfants malades, 149, rue de Sèvres, 75015 Paris.
Virologie (Montrouge, France)
|November 4, 2021
Summary
Rapid resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) develops quickly, limiting future HIV treatment options. Discontinuing NNRTIs after confirmed virologic failure is recommended due to loss of in vivo antiviral activity.
Area of Science:
- Virology
- Immunology
- Pharmacology
Context:
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are crucial in HIV therapy.
- Rapid development of NNRTI resistance is a significant clinical challenge.
- Understanding resistance profiles in different HIV-1 subtypes is essential.
Purpose:
- To analyze the rapid development of resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs).
- To investigate the impact of NNRTI resistance on viral fitness and future treatment options.
- To evaluate the efficacy of NNRTI interruption in patients with resistant HIV strains.
Summary:
- NNRTI therapy leads to rapid phenotypic resistance and cross-resistance, with minimal impact on viral fitness.
- NNRTI-selected mutations persist even without drug pressure, affecting treatment efficacy, especially in non-B subtypes.
- Single nevirapine doses for mother-to-child transmission prevention can select for resistance, impacting subsequent NNRTI regimens.
- Continued NNRTI therapy drives viral evolution, increasing resistance and limiting therapeutic choices.
- Interruption of NNRTIs in patients with resistant virus shows no significant immunologic or virologic benefit, indicating a loss of in vivo activity.
Impact:
- Findings suggest that NNRTIs lose their in vivo antiviral activity upon resistance development.
- Strong consideration should be given to discontinuing NNRTI therapy once virologic failure is confirmed.
- This research highlights the need for careful NNRTI treatment strategies to preserve future therapeutic options.
Related Concept Videos
01:10Retrovirus Life Cycles
47.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.6K
01:26Size and Structure of Viral Genomes
248
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
248
01:29Viruses with RNA Genomes
226
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
226
00:36Viral Mutations
34.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.7K
02:33Retroviruses
12.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K